Literature DB >> 19625760

Managing impaired glucose metabolism in acromegalic subjects.

V Pezzino, C Sipione, P Tita, R Vigneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19625760     DOI： 10.1007/BF03346553

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  9 in total

Review 1.  Medical progress: Acromegaly.

Authors:  Shlomo Melmed
Journal:  N Engl J Med       Date:  2006-12-14       Impact factor: 91.245

Review 2.  Pegvisomant in acromegaly: why, when, how.

Authors:  A Colao; G Arnaldi; P Beck-Peccoz; S Cannavò; R Cozzi; E degli Uberti; L De Marinis; E De Menis; D Ferone; V Gasco; A Giustina; S Grottoli; G Lombardi; P Maffei; E Martino; F Minuto; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

3.  Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.

Authors:  Cristina L Ronchi; Virginia Varca; Paolo Beck-Peccoz; Emanuela Orsi; Francesca Donadio; Andrea Baccarelli; Claudia Giavoli; Emanuele Ferrante; Andrea Lania; Anna Spada; Maura Arosio
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

4.  Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

Authors:  Ariel L Barkan; Pia Burman; David R Clemmons; William M Drake; Robert F Gagel; Philip E Harris; Peter J Trainer; Aart Jan van der Lely; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2005-08-02       Impact factor: 5.958

Review 5.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

Authors:  Annamaria Colao; Diego Ferone; Paolo Marzullo; Gaetano Lombardi
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

Review 6.  Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.

Authors:  Gherardo Mazziotti; Irene Floriani; Stefania Bonadonna; Valter Torri; Philippe Chanson; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

7.  Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study.

Authors:  Annamaria Colao; Renata S Auriemma; Mariano Galdiero; Paolo Cappabianca; Luigi M Cavallo; Felice Esposito; Ludovica F S Grasso; Gaetano Lombardi; Rosario Pivonello
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

8.  The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.

Authors:  Rune Lindberg-Larsen; Niels Møller; Ole Schmitz; Søren Nielsen; Marianne Andersen; Hans Orskov; Jens O L Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2007-03-06       Impact factor: 5.958

9.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.